Rainer Ehness
Nuernberg, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The Non-Interventional PAZOREAL Study to Assess the Effectiveness and Safety of Pazopanib in a Real-Life Setting: Reflecting a Changing mRCC Treatment Landscape.
Journal: Cancers
Published: October 18, 2022
Adjuvant treatment patterns and outcomes in patients with stage IB-IIIA non-small cell lung cancer in France, Germany, and the United Kingdom based on the LuCaBIS burden of illness study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 18, 2018
Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 25, 2018
Economic burden of advanced melanoma in France, Germany and the UK: a retrospective observational study (Melanoma Burden-of-Illness Study).
Journal: Melanoma research
Published: August 12, 2017
The PAZOREAL noninterventional study to assess effectiveness and safety of pazopanib and everolimus in the changing metastatic renal cell carcinoma treatment landscape.
Journal: Future oncology (London, England)
Published: May 20, 2017
Treatment patterns and outcomes of Stage IIIB/IIIC melanoma in France, Germany and the UK: A retrospective and prospective observational study (MELABIS).
Journal: International journal of clinical practice
Published: October 24, 2016
Economic Burden of Melanoma in Three European Countries: A Retrospective Observational Study.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026